HCA Fundamental Analysis & Score

HCA Healthcare, Inc. Healthcare Medical Care Facilities
$458.84
Quote dated October 16, 2026
62/100
Hold

What this score covers. It is a fixed screen of five reported ratios with no valuation input, so a company can score highly while its valuation risk remains elevated. The full report scores valuation separately, as one of nine scored sections. How the score is calculated

View Plans
Page generated: October 18, 2026 at 02:50 UTC

Key Financial Metrics

Market Cap
$99.34B
P/E Ratio (TTM)
15.4x
P/E Forward
14.3x
Revenue Growth
8.7%
Gross Margin
42.6%
Net Margin
8.8%

Rule-Based Financial Screen Summary

HCA Healthcare, Inc. (HCA) is a Healthcare company in the Medical Care Facilities industry. It has a 62/100 Hold score on our five-factor fundamentals screen. Key strengths include Gross Margin (42.6%). The score is a five-factor screen — revenue growth, gross margin, net margin, return on equity and debt-to-equity — each scored against fixed thresholds from a neutral starting point of 50 points. The full report scores nine sections, including moat, free cash flow, dilution and valuation, which this screen does not.

Revenue Growth: Moderate Gross Margin: Good Net Margin: Thin

This page score and the strengths and concerns above are produced by deterministic, rule-based calculations from the available third-party financial inputs documented below. AI does not choose the score, strengths, or concerns. Data and automated summaries can contain errors. This is not personalized investment advice. See our methodology and disclaimer.

How this page score was calculated

The calculation starts at 50 points and applies the five fixed adjustments shown below. Missing or invalid inputs contribute no adjustment. A finite provider-reported zero is treated as a measured value and evaluated against that input's displayed threshold. The pre-clamp result is 62; the published result is clamped to a minimum of 10 and maximum of 98, producing 62/100.

HCA score inputs and fixed adjustments
Input Displayed value Threshold applied Adjustment Data status
Revenue Growth 8.7% > 0% to 10% +4 Available
Gross Margin 42.6% > 35% to 50% +6 Available
Net Margin 8.8% > 0% to 10% +2 Available
Return on Equity Not available No threshold applied +0 Missing — contributes zero
Debt/Equity Not available No threshold applied +0 Missing — contributes zero

Score bands

80 or higher: Strong Buy; 65–79: Buy; 50–64: Hold; below 50: Caution.

These are fixed names for score ranges. The score is not a success probability, recommendation, or forecast, and 80/100 does not mean an 80% chance of a gain.

Not included in this score

  • Peer results or relative peer ranking
  • Demand zones or liquidity
  • Technical momentum
  • News or market sentiment
  • DCF valuation or the downloadable report score

Sources, freshness, and limitations

This page was generated . The provider identifies the latest underlying financial period as June 30, 2026. The displayed market quote is dated October 16, 2026. Generation time is not the same as the date of the underlying filing or market observation.

Financial inputs may be delayed, restated, differently standardized by the data provider, or unavailable. Missing, invalid, or non-finite values receive no positive or negative adjustment rather than being estimated. A finite provider-reported zero is retained and evaluated against that metric's displayed threshold; it is not treated as missing. This can make a sparse-data score less informative. The screen does not capture every business, market, valuation, or portfolio risk, and investors can lose money.

What the full HCA report adds

The 62/100 on this page comes from a fixed screen of 5 ratios. The downloadable report is a separate analysis with its own score, built from 9 weighted sections.

This page: fixed screen

  • Revenue Growth
  • Gross Margin
  • Net Margin
  • Return on Equity
  • Debt/Equity

Each factor is scored against fixed thresholds from a starting point of 50 points. No factor prices the stock, so valuation is not part of the 62/100.

Full report: 9 scored sections

  1. Business Moat weight 15 of 100
  2. Revenue Growth Consistency weight 14 of 100
  3. Margin Quality weight 12 of 100
  4. Free Cash Flow Strength weight 12 of 100
  5. Balance Sheet Safety weight 12 of 100
  6. Returns on Capital weight 12 of 100
  7. Dilution vs Self-Funded Growth weight 8 of 100
  8. Valuation vs Growth weight 10 of 100
  9. Structural vs Cyclical Growth weight 5 of 100

When the inputs allow, the report also shows a fair-value estimate with its discounted cash flow (DCF) assumptions and a 3×3 sensitivity table, a confidence figure, and the data limitations that reduced that confidence. Its headline label can add a valuation-risk flag next to the fundamental-quality rating.

Open the HCA report page

Supplementary Metrics for HCA

2 data points drawn from analyst targets, consensus estimates, and ownership data. These are supplementary observations, not event predictions or causal explanations:

The provider-reported third-party analyst consensus category is Buy; it is not a StrongBuyAnalytics recommendation.
The current provider record reports institutional ownership of 78.8%.

Risk Indicators for HCA

1 measurable indicator visible in HCA Healthcare, Inc.'s reported numbers. These are market and valuation risk metrics — not a comprehensive list of business risks, which would require qualitative analysis beyond this data:

The provider-reported short ratio is 3.2 days to cover. Short-interest data can be delayed and may reflect hedging or other strategies, so it does not establish investor intent or future direction.

HCA Balance Sheet & Cash Flow

HCA Healthcare, Inc.'s liquidity and cash generation as of the most recent filing — note the cash position of $1.13B against $51.55B of debt:

Total Cash
$1.13B
Total Debt
$51.55B
Current Ratio
0.99
FCF Yield
3.8%
EBITDA
$15.75B
Operating Margin
15.2%

These are provider-normalized figures and may differ from the issuer's as-filed presentation, units, or latest amendment. Use source filings for verification.

HCA Valuation Snapshot

Trailing P/E
15.4x
Fairly valued
Forward P/E
14.3x
Earnings growth expected
PEG Ratio
1.40
Fairly valued
Analyst Target (Mean)
$460.59
Range: $380 – $579
Dividend Yield
0.68%
5Y avg: 0.77%
52-Week Price Range — HCA is trading at 52% of its range
$353.99 (52W Low) $556.52 (52W High)

Who Holds HCA? — Institutional 13F Filings

Institutional investment managers with >$100 M in qualifying assets must disclose their equity positions quarterly on SEC Form 13F — typically within 45 days of quarter-end. Search those filings below to see which hedge funds, mutual funds, and asset managers reported HCA as a holding, how many shares they held, and how positions changed quarter over quarter.

Search 13F Filings for HCA Free · no sign-in required · live SEC EDGAR data
What you see free
Which institutions reported HCA, share counts, reported values, and direct links to the SEC filing.
Research Pro adds
Full manager portfolios — every position a fund holds, quarter-over-quarter changes, and concentration weights.
Data limitation
13F reports covered long positions for the filing's stated reporting period, typically a quarter-end—not on its later submission date. Short positions, full derivatives, and current intent are not disclosed.

How to Interpret the HCA Fundamentals Score

HCA rates 62/100 on our five-factor fundamentals screen, which puts it in the "Hold" band. The band name describes a fixed range in this model; it is not a recommendation or prediction. The calculation above shows how each reported input affected the result.

62/100 · Hold band

HCA Healthcare, Inc. clears some of our thresholds and misses others. On the positive side, gross margin (42.6%). A middling score means the fundamentals are genuinely ambiguous, not that we have hedged.

HCA Earnings & Revenue Outlook

HCA Healthcare, Inc. reported revenue growth of 8.7% year over year, against a Medical Care Facilities peer set where scale and pricing power vary widely. That is solid but not exceptional, so it lifts the score without dominating it.

Earnings grew 11.6% over the same period, outpacing revenue — a sign of operating leverage.

Track upcoming report dates on our earnings calendar.

HCA Fundamental Factors to Monitor

This is a review of reported fundamentals, not a price target or an estimate of future returns. These are the current figures that may be useful to monitor as new filings become available.

Mixed current reading: Revenue growth of 8.7% sits alongside metrics that neither help nor hurt the score materially. Watch whether those reported inputs move across the disclosed thresholds.

Positive Fundamental Inputs for HCA

These are the HCA Healthcare, Inc. figures that push the score up, taken straight from the most recent reported financials:

  • Gross Margin (42.6%)

Learn More About Stock Analysis

Free 14-Min Course
Instructor
StrongBuy Analytics
Fundamental Research Team
How to Read Your Research Report
14Min
15Chapters
FreeNo sign-up

See how the metrics on this HCA page — quality score, valuation, DCF scenarios, confidence labels, and data limitations — are organized in the downloadable research report.

Generate My Free HCA Report

Guides to the specific measures used in this HCA analysis:

Fundamental Analysis Guide

How the financial statements behind this page fit together.

Understanding P/E Ratio

What HCA's 15.4x multiple does and does not tell you.

Stock Valuation Methods

How DCF, multiples and asset-based approaches value a company like HCA Healthcare, Inc..

DCF Assumptions and Limitations

What a discounted cash flow estimate for HCA depends on, and where it breaks down.

How to Read an AI Stock Report

What each section of a HCA report is for, and what it leaves out.

How to Read Earnings Reports

Where the HCA growth and margin figures on this page come from.

What Are Demand Zones?

The technical side we deliberately keep out of the HCA score.

Related Tools for HCA

Semiconductor Demand Zone Tracker HCA Live Chart HCA SEC Filing News Earnings Calendar Institutional Ownership Sector Scanner Average Down Calculator

HCA SEC Filing News

Latest SEC filings for HCA explained in plain English — insider buys/sells (Form 4), proposed sales (Form 144), material events (8-K), and quarterly & annual reports.

Loading recent SEC filings…
View all HCA SEC Filing News →

Frequently Asked Questions about HCA

Support and resistance are technical levels, so they are not part of the fundamentals score. Our demand zones page tracks semiconductor stocks; coverage does not extend to every ticker. Use the chart tool to identify price levels for HCA manually.

This HCA analysis is for educational and informational purposes only and does not constitute financial advice. Figures come from third-party feeds and can be delayed, standardized, incomplete, or inaccurate; verify material facts in primary filings and identified sources. Past performance does not guarantee future results. Read our full disclaimer.